These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 322579)

  • 1. [Antigenic sites implicated in tumour allograft enhancement].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1977; 128(1-2):19-20. PubMed ID: 322579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of in vitro and in vivo activities of isoantibodies directed against idiotypes and recognition structures for transplantation antigens.
    Kinsky RG; Duc HT; Fuensalida E
    Folia Biol (Praha); 1978; 24(2):81-94. PubMed ID: 26614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dominant role of Ia antibodies in the passive enhancement of H-2 incompatible skin grafts.
    Staines NA; Guy K; Davies DA
    Eur J Immunol; 1975 Nov; 5(11):782-9. PubMed ID: 802473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ia versus K/D antigens in immunological enhancement of tumor allografts.
    Duc HT; Kinsky RG; Voisin GA
    Transplantation; 1978 Apr; 25(4):182-7. PubMed ID: 635985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic properties of transplantation immune sera. IV. Influence of the course of immunization, dilution and complexing to antigen on enhancing activity of Ig classes.
    Duc HT; Kinsky RG; Kanellopoulos J; Voisin GA
    J Immunol; 1975 Oct; 115(4):1143-50. PubMed ID: 1176768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enhancing antibodies and supressive cells in maternal anti-fetal immune reaction].
    Chaouat G; Voisin GA; Daëron M; Kanellopoulos J
    Ann Immunol (Paris); 1977; 128(1-2):21-4. PubMed ID: 848875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
    Sobotková E; Nouza K
    Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
    Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
    Perry LL; Williams IR
    J Immunol; 1985 May; 134(5):2935-41. PubMed ID: 2580008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative effectiveness of rabbit anti-mouse thymocyte sera in potentiating the survival of mouse skin or tumour allografts made across the H-2 barrier.
    Lai T; Symes MO
    Immunology; 1976 Jul; 31(1):21-6. PubMed ID: 800400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
    Jansen JL; Koene RA; Kamp GJ; Hagemann JF; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):392-4. PubMed ID: 1097512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic studies and effect on skin allograft survival of DBA-2 DAG, Ly, and M-locus antigens.
    Sachs JA; Huber B; Peña-Martinez J; Festenstein H
    Transplant Proc; 1973 Dec; 5(4):1385-7. PubMed ID: 4590621
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
    Nevala WK; Paul C; Wettstein PJ
    J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.